Natures Sunshine Products market cap NATR

Share price times shares outstanding: what the whole company sells for, since 2011.

Natures Sunshine Products is worth $213.8M at the close on Oct 23, 2026, at $12.15 a share.

That is down 14% over the last year and down 32% over five years.

Its highest close in our data was $484.3M in Feb 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$213.8M	$213.8M	$484.3M	−43%
2025	$378.1M	$211.8M	$397.8M	+36%
2024	$277.5M	$233.8M	$390.9M	−16%
2023	$329.8M	$161.6M	$343M	+107%
2022	$159.5M	$155.2M	$369.7M	−56%
2021	$365.6M	$288.7M	$412.1M	+24%
2020	$293.9M	$140.4M	$293.9M	+72%
2019	$171.3M	$151.7M	$195.6M	+15%
2018	$148.8M	$137.9M	$226.8M	−32%
2017	$218.3M	$162.2M	$263.1M	−22%
2016	$281.3M	$139.2M	$300M	+50%
2015	$188.1M	$188.1M	$275.7M	−32%
2014	$275.9M	$214.4M	$295.6M	−3%
2013	$283.8M	$224.7M	$311M	+29%
2012	$220.7M	$205.3M	$275M	−9%
2011	$241.6M	$218.5M	$295.3M	n/a

Companies in Drug Manufacturers - General nearest Natures Sunshine Products' size, closest first, today.

Company	Market cap
NATRNatures Sunshine Products	$213.8M
ARVNArvinas	$477.3M
PBYIPuma Biotechnology	$568.9M
IRWDIronwood Pharmaceuticals	$571.7M
ZVRAZevra Therapeutics	$582.6M
CRMDCorMedix	$611.9M
LFVNLifevantage	$73.4M
SPROSpero Therapeutics	$64.6M
COLLCollegium Pharmaceutical	$747.5M
ABUSArbutus Biopharma	$831M
ATNMActinium Pharmaceuticals	$47.8M
Peer median	$570.3M